Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Grey-matter texture abnormalities and reduced hippocampal volume are distinguishing features of schizophrenia.

Radulescu E, Ganeshan B, Shergill SS, Medford N, Chatwin C, Young RC, Critchley HD.

Psychiatry Res. 2014 Sep 30;223(3):179-86. doi: 10.1016/j.pscychresns.2014.05.014. Epub 2014 Jun 7.

PMID:
25028155
2.

Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study.

Kuroki N, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Ersner-Hershfield H, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW.

Am J Psychiatry. 2006 Dec;163(12):2103-10.

3.

Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.

Suzuki M, Zhou SY, Takahashi T, Hagino H, Kawasaki Y, Niu L, Matsui M, Seto H, Kurachi M.

Brain. 2005 Sep;128(Pt 9):2109-22. Epub 2005 Jun 1.

PMID:
15930048
4.

Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings.

Guo W, Hu M, Fan X, Liu F, Wu R, Chen J, Guo X, Xiao C, Quan M, Chen H, Zhai J, Zhao J.

Schizophr Res. 2014 Oct;159(1):43-50. doi: 10.1016/j.schres.2014.07.051. Epub 2014 Aug 23.

PMID:
25156295
5.
6.

Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia.

Cooper D, Barker V, Radua J, Fusar-Poli P, Lawrie SM.

Psychiatry Res. 2014 Jan 30;221(1):69-77. doi: 10.1016/j.pscychresns.2013.07.008. Epub 2013 Nov 14.

PMID:
24239093
7.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
8.

Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.

McClure RK, Phillips I, Jazayerli R, Barnett A, Coppola R, Weinberger DR.

Psychiatry Res. 2006 Dec 1;148(2-3):121-32. Epub 2006 Nov 9.

PMID:
17097276
9.

Grey matter changes over time in high risk subjects developing schizophrenia.

Job DE, Whalley HC, Johnstone EC, Lawrie SM.

Neuroimage. 2005 May 1;25(4):1023-30.

PMID:
15850721
10.

Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings.

Hu M, Li J, Eyler L, Guo X, Wei Q, Tang J, Liu F, He Z, Li L, Jin H, Liu Z, Wang J, Liu F, Chen H, Zhao J.

Schizophr Res. 2013 Mar;144(1-3):37-42. doi: 10.1016/j.schres.2012.12.018. Epub 2013 Jan 27. Review.

PMID:
23360727
11.

The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review.

Kakeda S, Korogi Y.

Neuroradiology. 2010 Aug;52(8):711-21. doi: 10.1007/s00234-010-0717-2. Epub 2010 May 22. Review.

PMID:
20495793
12.

Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

Mathew I, Gardin TM, Tandon N, Eack S, Francis AN, Seidman LJ, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS.

JAMA Psychiatry. 2014 Jul 1;71(7):769-77. doi: 10.1001/jamapsychiatry.2014.453.

PMID:
24828364
13.

Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia.

Witthaus H, Mendes U, Brüne M, Ozgürdal S, Bohner G, Gudlowski Y, Kalus P, Andreasen N, Heinz A, Klingebiel R, Juckel G.

J Psychiatry Neurosci. 2010 Jan;35(1):33-40.

14.

Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies.

Yu KK, Cheung C, Chua SE, McAlonan GM.

J Psychiatry Neurosci. 2011 Nov;36(6):412-21. doi: 10.1503/jpn.100138.

15.

Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.

Davatzikos C, Shen D, Gur RC, Wu X, Liu D, Fan Y, Hughett P, Turetsky BI, Gur RE.

Arch Gen Psychiatry. 2005 Nov;62(11):1218-27.

PMID:
16275809
16.

Voxel-based morphometric analysis of gray matter in first episode schizophrenia.

Kubicki M, Shenton ME, Salisbury DF, Hirayasu Y, Kasai K, Kikinis R, Jolesz FA, McCarley RW.

Neuroimage. 2002 Dec;17(4):1711-9.

17.

Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia.

Wolf RC, Höse A, Frasch K, Walter H, Vasic N.

Eur Psychiatry. 2008 Dec;23(8):541-8. doi: 10.1016/j.eurpsy.2008.02.002. Epub 2008 Apr 22.

PMID:
18434103
18.

Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry.

Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM.

Neuroimage. 2002 Oct;17(2):880-9.

PMID:
12377162
19.

Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.

Nenadic I, Dietzek M, Schönfeld N, Lorenz C, Gussew A, Reichenbach JR, Sauer H, Gaser C, Smesny S.

Schizophr Res. 2015 Feb;161(2-3):169-76. doi: 10.1016/j.schres.2014.10.041. Epub 2014 Dec 12.

PMID:
25497442
20.

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome.

Radulescu E, Ganeshan B, Minati L, Beacher FD, Gray MA, Chatwin C, Young RC, Harrison NA, Critchley HD.

Pharmacogenomics J. 2013 Feb;13(1):70-9. doi: 10.1038/tpj.2012.3. Epub 2012 Feb 14.

PMID:
22333911

Supplemental Content

Support Center